Sources: Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B (Bloomberg)
Isomorphic Labs, an AI-powered drug discovery startup spun out of Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to Bloomberg.
The company is focused on using AI for drug discovery.
No further details on the funding talks were reported.
Brief written by urgent.news from Techmeme, 9to5Google — 2 reports on this story. Machine-written — may contain errors; check the original before relying on it.
